Journal article
Colchicine exerts anti-atherosclerotic and ‑plaque-stabilizing effects targeting foam cell formation
N Schwarz, S Fernando, YC Chen, T Salagaras, SR Rao, S Liyanage, AE Williamson, D Toledo-Flores, C Dimasi, TJ Sargeant, J Manavis, E Eddy, P Kanellakis, PL Thompson, JTM Tan, MF Snel, CA Bursill, SJ Nicholls, K Peter, PJ Psaltis
FASEB Journal | Published : 2023
Abstract
Colchicine is a broad-acting anti-inflammatory agent that has attracted interest for repurposing in atherosclerotic cardiovascular disease. Here, we studied its ability at a human equivalent dose of 0.5 mg/day to modify plaque formation and composition in murine atherosclerosis and investigated its actions on macrophage responses to atherogenic stimuli in vitro. In atherosclerosis induced by high-cholesterol diet, Apoe−/− mice treated with colchicine had 50% reduction in aortic oil Red O+ plaque area compared to saline control (p =.001) and lower oil Red O+ staining of aortic sinus lesions (p =.03). In vitro, addition of 10 nM colchicine inhibited foam cell formation from murine and human ma..
View full abstractGrants
Awarded by National Hospice Foundation
Funding Acknowledgements
DHAC | National Health and Medical Research Council (NHMRC), Grant/Award Number: 1127159, 1128046, 1111630 and 1161506; National Heart Foundation of Australia (Heart Foundation), Grant/Award Number: VG10137, FLF102068 and FLF102056; Sylvia and Charles Viertel Charitable Foundation (SCVCF), Grant/Award Number: VIERCI2017016